CD4+ CD56+ hematodermic neoplasm

American Journal of Dermatopathology

Volumn 29, Issue 1, 2007, Pages 59-61

  Cibull, Thomas L ^a   Thomas, Antoinette B ^a   O'Malley, Dennis P ^a   Billings, Steven D ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b Department of Pathology and Laboratory Medicine ^*  (United States)

Author keywords

CD4+CD56+ hematodermic neoplasm; Cutaneous hematopoietic neoplasm

Indexed keywords

ADIPOSE TISSUE; AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CD4+ CD56+ HEMATODERMIC NEOPLASM; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; SKIN TUMOR;

AGED; ANTIGENS, CD4; ANTIGENS, CD56; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; PROGNOSIS; SKIN NEOPLASMS;

EID: 33846891986     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000245203.67386.75     Document Type: Article

References (11)

1. Jacob MC, Chaperot C, Mossuz P. CD4+CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematogica. 2003;88:941-955.
2. Petrella T, Dalac S, Maymadie M. CD4+CD56+ cutaneous neoplasms: a distinct hematologic entity? Am J Surg Pathol. 1999;23:137-146.
3. Petrella T, Comeau MR, Maynadie M, et al. "Agranular CD4+CD56+ hematodermic neoplasm" (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26:852-862.
4. Willemze R, Jaffe ES, Burg G, et al. WHO-ERORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
5. Chamaillard M, Beylot-Barry M, Viallard JF, et al. Agranular CD4+CD56+ hematodermic neoplasm: a new case report. Ann Dermatol Venereol. 2004;131:1074-1076.
6. Petrella T, Meijer CJ, Dalac S, et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol. 2004;122:307-313.
7. Machet L, De Muret A, Wiezberka E, et al. Agranular CD4+CD56+CD123+ hematodermic neoplasm (blastic NK-cell Lymphoma) revealed by cutaneous localization: 2 cases. Ann Dermatol Venereol. 2004;131:969-973.
8. Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123:662-675.
9. Urosevic M, Conrad C, Kamarashev J, et al. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol. 2005;36:1020-1024.
10. Ng AP, Lade S, Rutherford T, et al. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases. Haematologica. 2006;91:143-144.
11. Weedon D. Skin Pathology. 2nd ed. New York, NY: Churchill Livingstone; 2002:1095-1124.